Trump, Kamala Harris and UBS
Certara (CERT) stock rises 10% after UBS upgrade to Buy citing strong growth potential in biosimulation software and Model ...
UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...
A recent UBS Investor Watch report highlights a deeply divided country in which many view the economy as the main issue this ...
Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...
Italy's Treasury said on Friday it had picked UBS Europe SE and White & Case Europe LLP as financial and legal advisers for ...
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
UBS expanded its FX sales capabilities by leveraging cutting-edge tools and platforms to enhance operational efficiency and ...
Swiss bank UBS is running around six months ahead of schedule in its cost savings efforts and its integration of Credit ...
UBS analyst Charles Eden maintained a Buy rating on Symrise (0G6T – Research Report) today and set a price target of €139.00. The ...
Through the breadth of its market liquidity, product scale and global footprint, UBS has built a strong reputation as the ...
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback